Heart News and Research

RSS

HbA1c can be deceptive in African American children with diabetes: Study

Researchers at LSU Health Sciences Center New Orleans and Children's Hospital of New Orleans have found that there is a major difference in the hemoglobin A1c response to blood glucose between African-American and Caucasian children with diabetes. HbA1c is the main test used to monitor diabetes and guide treatment decisions.

5 May 2010

Palatin Technologies granted patent relating to small molecule compounds that bind to melanocortin receptors

Palatin Technologies, Inc. announced that the U.S. Patent and Trademark Office issued U.S. Patent No. 7,709,484, titled "Substituted Melanocortin Receptor-Specific Piperazine Compounds," today. The claims in the issued patent relate to small molecule compounds which bind to melanocortin receptors.

5 May 2010

HHS announces $16M award for Geisinger to create Keystone Beacon Community

Today the Department of Health and Human Services announced that Geisinger Health System will receive $16 million to create the Keystone Beacon Community as part of HHS's Beacon Community cooperative program.

5 May 2010

TCT for Surgeons to showcase hybrid surgical, interventional techniques during TCT 2010

TCT for Surgeons will showcase the expansion of hybrid surgical and interventional techniques in the field that are improving outcomes for patients undergoing cardiac surgery. Now in its 4th year, the course will run during Transcatheter Cardiovascular Therapeutics 2010 (September 21-25), the annual scientific symposium of the Cardiovascular Research Foundation.

5 May 2010

Non-compliance, NSAIDs use inhibit clinical benefit of aspirin

Charles H. Hennekens, M.D., the first Sir Richard Doll Research Professor in the Charles E. Schmidt College of Biomedical Science at Florida Atlantic University, was the first to demonstrate that aspirin prevents a first heart attack based on his landmark Physicians Health Study (PHS).

5 May 2010

Medication used to treat heart arrhythmias also reduces myotonic dystrophy: Researchers

A medication most often used to treat heart arrhythmias also reduces a central symptom of myotonic dystrophy, the most common type of muscular dystrophy in adults.

5 May 2010

High doses of antioxidant nutritional supplements may predispose cells to develop cancer

High doses of antioxidant nutritional supplements, such as vitamins C and E, can increase genetic abnormalities in cells, which may predispose supplement-takers to developing cancer, according to a new study from the Cedars-Sinai Heart Institute.

5 May 2010

Bundling could save health care dollars if snags are overcome

"Bundling payments to hospitals and doctors for episodes of care is gaining momentum in the federal government and in the private sector as a way to increase provider accountability and improve care -- but lingering challenges may deter its application on a broader scale."

5 May 2010

Researchers receive NIDDK grant to identify pre-diabetes symptoms

A Biodesign team of researchers, led by Randall Nelson, PhD, has received a new five-year, $3.1 million award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health. Their goal is to discover and validate telltale molecular signs to learn how to predict who will develop the disease long before any symptoms of diabetes appear.

5 May 2010

Clinical preventive services can reduce death rates

"Prevention is the best medicine," the saying goes. According to a new study, increasing the use of that medicine could prevent a significant number of adult deaths annually.

5 May 2010

Cardica reports net loss of $3.0 million for third-quarter fiscal 2010

Cardica, Inc. today announced financial results for its fiscal third quarter and nine months ended March 31, 2010. Cardica's management will host a conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide an update on the company's business.

5 May 2010

Idera Pharmaceuticals reports net loss of $1.9M for first-quarter 2010

Idera Pharmaceuticals, Inc., a biotechnology company engaged in the discovery and development of DNA- and RNA-based drug candidates targeted to Toll-like Receptors, today reported financial results for the first quarter ended March 31, 2010.

5 May 2010

Healthy & happy lifestyle – key to touching 100 years of life, says study

In a new study the secret for a longer life is uncovered. Not surprisingly it lies more in a healthy and happy lifestyle than in just genetics. Researchers say that being a Centenarian is increasingly more common these days.

4 May 2010

NMT Medical reports total revenues of $3.0M for first-quarter 2010

NMT Medical, Inc., an advanced medical technology company that designs, develops, manufactures and markets proprietary implant technologies that allow interventional cardiologists to treat structural heart disease through minimally invasive, catheter-based procedures, today announced financial results for the quarter ended March 31, 2010.

4 May 2010

Cardiovascular specialists demonstrate effectiveness of using stents to repair aortas

A UC Davis team of cardiovascular specialists has demonstrated the effectiveness of using stents -- as compared to traditional open-chest surgery -- to repair aortas that are torn as the result of accidents. The researchers will present their findings at the American Association for Thoracic Surgery Aortic Symposium 2010, which takes place April 29-30 in New York City.

4 May 2010

MicroStockProfit.com releases Hansen Medical investment report

MicroStockProfit.com announces an investment report featuring Hansen Medical Inc.. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

4 May 2010

JNM supplement examines advances in cardiovascular molecular imaging

The Journal of Nuclear Medicine -the top-rated medical imaging journal worldwide-has published Multimodality Molecular Imaging of the Cardiovascular System, presenting the state of the art of cardiovascular molecular imaging and discussing opportunities and challenges in advancing cardiovascular molecular imaging to clinical practice.

4 May 2010

Isolated microalgal strain produces significant amounts of DGLA that helps reduce risk for heart attacks

Ben-Gurion University of the Negev (BGU) researchers have isolated a microalgal strain which produces large amounts of a polyunsaturated fatty acid that could reduce blood pressure, chronic inflammation and blood cholesterol level, reducing the risk for heart attacks.

4 May 2010

New study shows people with BAV more likely to have brain aneurysms

A new study shows that people with a common heart defect may also be more likely to have brain aneurysms. The study is published in the May 4, 2010, print issue of Neurology, the medical journal of the American Academy of Neurology.

4 May 2010

Deficiency of frataxin protein causes Friedreich's ataxia

The defective gene responsible for Friedreich's ataxia was identified over 20 years ago, but so far our ideas of how this gene causes the disease have been merely speculative. It was assumed that, as a result of the mutation, the gene could no longer be transcribed because this stretch of DNA was inaccessible. FMI Group Leader Marc Bühler and his team have now carried out experiments demonstrating that this is not the case and revealing what actually happens in Friedreich's ataxia.

4 May 2010